Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China
Condition(s):Atypical Hemolytic UremicLast Updated:February 21, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Atypical Hemolytic UremicLast Updated:February 21, 2024Recruiting
Condition(s):Paroxysmal Nocturnal HemoglobinuriaLast Updated:January 5, 2024Active, not recruiting
Condition(s):Thrombotic MicroangiopathiesLast Updated:January 27, 2023Not yet recruiting
Condition(s):Hemolytic-Uremic Syndrome, AtypicalLast Updated:March 1, 2024Active, not recruiting
Condition(s):Hypertensive Emergency-associated Hemolytic Uremic SyndromeLast Updated:January 5, 2024Recruiting
Condition(s):Neuromyelitis Optica; Neuromyelitis Optica Spectrum DisorderLast Updated:October 16, 2023Active, not recruiting
Condition(s):Guillain-Barre SyndromeLast Updated:February 9, 2024Completed
Condition(s):HELLP Syndrome (HELLP), Third Trimester; Complement Abnormality; Morbidity;Newborn; Maternal Injury; Preeclampsia SevereLast Updated:November 14, 2023Completed
Condition(s):Thrombotic Microangiopathies; Atypical Hemolytic Uremic Syndrome; Multiple Organ Dysfunction SyndromeLast Updated:September 21, 2023Completed
Condition(s):Healthy SubjectsLast Updated:May 15, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.